Furthermore, significant differences were observed between PERP and Akt positive expression in precancerous (72.8% vs. 37.7%) and benign tumors (26.6% vs. 0.9%) (p = 0.001 for both comparisons). This evidence concerns the gene AKT1 and benign neoplasm.